Novartis AG

Novartis AGverified




Market Cap:


Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients an...[Read more]


Drug Manufacturers - General

IPO Date


Stock Exchange




The PE Ratio as of May 2024 (TTM) for Novartis AG (NVS) is 23.31

According to Novartis AG’s latest financial reports and current stock price. The company's current PE Ratio is 23.31. This represents a change of 25.97% compared to the average of 18.50 of the last 4 quarters.

Novartis AG (NVS) Historical PE Ratio (quarterly & annually)

How has NVS PE Ratio performed in the past?

The mean historical PE Ratio of Novartis AG over the last ten years is 18.72. The current 23.31 PE Ratio has changed 12.35% with respect to the historical average. Over the past ten years (40 quarters), NVS's PE Ratio was at its highest in in the December 2019 quarter at 45.10. The PE Ratio was at its lowest in in the December 2021 quarter at 2.84.

Quarterly (TTM)









Novartis AG (NVS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Novartis AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 248.42%

Maximum Annual PE Ratio = 28.72

Minimum Annual Increase = -69.35%

Minimum Annual PE Ratio = 7.73

Quarterly (TTM)
YearPE RatioChange

Novartis AG (NVS) Average PE Ratio

How has NVS PE Ratio performed in the past?

The current PE Ratio of Novartis AG (NVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Novartis AG (NVS) PE Ratio vs. Peers

How is NVS’s PE Ratio compared to its peers?

Novartis AG’s PE Ratio is less than AstraZeneca PLC (37.63), less than GSK plc (32.12), greater than Roche Holding AG (1.38), greater than Bristol-Myers Squibb Company (-14.49), greater than Sanofi (15.77), less than Merck & Co., Inc. (144.10), greater than Bayer Aktiengesellschaft (-2.27), less than Gilead Sciences, Inc. (174.48), greater than Johnson & Johnson (9.68), less than AbbVie Inc. (49.12), less than Eli Lilly and Company (113.00), greater than Pfizer Inc. (-547.35),

Build a custom stock screener for Novartis AG (NVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novartis AG (NVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Novartis AG's PE Ratio?

How is the PE Ratio calculated for Novartis AG (NVS)?

What is the highest PE Ratio for Novartis AG (NVS)?

What is the 3-year average PE Ratio for Novartis AG (NVS)?

What is the 5-year average PE Ratio for Novartis AG (NVS)?

How does the current PE Ratio for Novartis AG (NVS) compare to its historical average?